Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction

View source ↗

Summary

A completed clinical trial investigates whether predictive urodynamic parameters can forecast the efficacy of onabotulinumtoxinA (Botox) for neurogenic bladder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Gaziantep | Conditions: Neurogenic Bladder Disorder | Status: COMPLETED